|
179. |
Kolkhir, P., Komi, D. E. A., Metz, M., Siebenhaar, F., and Maurer, M.+: Understanding human mast cells: lesson from therapies for allergic and non-allergic diseases. Nat. Rev. Immunol. 2022: 22; 294-308. IF: 100.30 |
r.179
|
169. |
Maurer, M.+, Khan, D. A., Komi, D. E. A., and Kaplan, A. P.: Biologics for the use in chronic spontaneous urticaria: when and which? J. Allergy Clin. Immunol. Pract. 2021: 9; 1067-1078. IF: 11.02 |
r.169
| 416. | Matanis, L.*, Eiza, N.*, Sabag, A., Bejar, J., Giménez-Arnau, A. M., Maurer, M., and Vadasz, Z.+: The expression of IL-17, in chronic spontaneous urticaria is linked to semaphorin5A. Biomolecules 2021: 11; 373. IF: 6.06 |
o.416
The expression of IL-17, in chronic spontaneous urticaria is linked to semaphorin5A Read More »
| 399. | Kröger, M., Scheffel, J., Nikolaev, V. V., Shirshin, E. A., Siebenhaar, F., Schleusener, J., Lademann, J., Maurer, M., and Darvin, M. E.+: In vivo non-invasive staining-free visualization of dermal mast cells in healthy, allergy and mastocytosis humans using two-photon fluorescence lifetime imaging. Sci. Rep. 2020: 10; 14930. IF: 4.38 |
o.399
| 396. | Folkerts, J., Redegeld, F., Folkerts, G., Blokhuis, B., van den Bergen, M. P. M., de Bruijn, M. J. W., van IJcken, W. F. J., Junt, T., Tam, S.-Y., Galli, S. J., Hendriks, R. W., Stadhouders, R.+, and Maurer, M.+: Butyrate inhibits human mast cell activation via epigenetic regulation of FceRI-mediated signaling. Allergy 2020: 75; 1966-1978. IF: 13.15 |
o.396
| 32. | Maurer, M., Magerl, M., Zuberbier, T., and Weller, K.: Urticaria. In: Kabashima, K., editor: Immunology of the skin. Japan: Springer, 2016 |
| 218 | Serra-Pages, M., Torres, R., Plaza, J., Herrerias, A., Costa-Farré, C., Jiménez, M., Maurer, M. Picado, C., and de Mora, F.+: Activation of the prostaglandin E2 receptor EP2 prevents house dust mite-induced airway hyperresponsiveness and inflammation by restraining mast cells activity. Clin. Exp. Allergy 2015: 45; 1590-1600. IF: 5.58 |
o.218
| 275 | Meyer, N., Woidacki, K., Maurer, M. and Zenclussen, A. C.: Safeguarding of fetal growth by mast cells and natural killer cells: deficiency of one is counterbalanced by the other. Front. Immunol. 2017: 8; 711. IF: 5.51 |
| 290 | Suender, C. A., Leist, M., Abrink, M., Valentin, P., Geldmacher, A., Steinhoff, M., Metz, M., and Maurer, M.+: Mast cells are critical for the limitation of thrombin-induced skin inflammation. Exp. Dermatol. 2018: 27; 50-57. IF: 2.87 |
Mast cells are critical for the limitation of thrombin-induced skin inflammation Read More »
| 69. | Valent, P., Arock, M., Bonadonna, P., Brockow, K., Broesby-Olsen, S., Escribano, L., von Gleixner, K., Grattan, C., Hadzijusufovic, E., Hägglund, H., Hermine, O., Horny, H. P., Kluin-Nelemans, H. C., Maurer, M., Niedoszytko, M., Nedoszyotko, B., Nilsson, G., Oude Elberink, H. N. G., Orfao, Radia, D., A., Reiter, A., Siebenhaar, F., Sotlar, K., Sperr, W. R., Triggiani, M., VanDormaal, J. J., Várkonyi, J., Yavuz, S., and Hartmann, K.: European Competence Network on Mastocytosis (ECNM): 10-year jubilee, update, and future perspectives. Wien. Klin. Wochenschr. 2012: 124; 807-814. IF: 0.81 |